BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, January 10, 2026
Home
»
Authors
» Brady Huggett
Brady Huggett
Articles
ARTICLES
Peregrine Gets FDA OK For Cotara Phase III, Awaits Partner
Feb. 25, 2003
By
Brady Huggett
Peregrine Gets FDA OK For Cotara Phase III, Awaits Partner
Feb. 25, 2003
By
Brady Huggett
BioMarin Raises $75M Publicly, Gets Good News On Aldurazyme
Feb. 24, 2003
By
Brady Huggett
BioMarin Raises $75M Publicly, Gets Good News On Aldurazyme
Feb. 24, 2003
By
Brady Huggett
Biogen's Amevive Shot Down In Europe; Approval Years Away
Feb. 21, 2003
By
Brady Huggett
SomaLogic Raises $19.5M To Develop Proteomics Products
Feb. 21, 2003
By
Brady Huggett
Biogen's Amevive Shot Down In Europe; Approval Years Away
Feb. 21, 2003
By
Brady Huggett
SomaLogic Raises $19.5M To Develop Proteomics Products
Feb. 21, 2003
By
Brady Huggett
BattellePharma Raises $22M To Develop Inhalation Program
Feb. 20, 2003
By
Brady Huggett
BattellePharma Raises $22M To Develop Inhalation Program
Feb. 20, 2003
By
Brady Huggett
View All Articles by Brady Huggett
